Every Form of Hormonal Contraceptive Is Found to be Linked to Increased Breast Cancer Risk

Every Form of Hormonal Contraceptive Is Found to be Linked to Increased Breast Cancer Risk

Since its foray onto the market, hormonal contraception options
have been surrounded by a somewhat-gray area of risk. Doctors and women alike
have hoped that newer, low-dose contraceptive pills, IUDs and implants lowered
the risk of breast cancer (some studies even touted the idea these eliminated
the risk entirely) when compared to their higher-dose counterparts, but a new
Danish study—it’s been dubbed the largest study of its kind—says even lower-dose
methods elevate the risk for breast cancer.

The research published in the New England Journal of Medicine on Wednesday was based around a
study of 1.8 million women between the ages of 15 and 49. Over the course of 11
years, researchers aimed to understand what would occur to these women who used
hormonal birth control (often a combined estrogen and progestin, but also
tested the patch, the ring, implants and IUDs) versus women who relied on
non-hormonal contraceptives (condoms, diaphragm or copper IUDs).

You May Also Like: Which Birth Control Gives You Better Skin, And Which Makes It Worse

The results are startling. Women who stayed on hormone-releasing contraceptives for 10 or more years experienced a 38-percent increase in their risk of developing breast cancer, compared with nonusers. By contrast, there was no increased risk for breast cancer seen in women who used hormones for less than one year. Even more, the new study estimated that for every 100,000 women,
hormone contraceptive use causes an additional 13 breast cancer cases a year, meaning that for
every 100,000 women using hormonal birth control, there are 68 cases of breast cancer
annually, compared with 55 cases a year among non-users. 

Because the research tracked the long-term effects of multiple
types of contraceptives, as well, the study was able to determine whether modern
options (like IUDs and the patch) are “safer” than the pill. The answer: it
didn’t matter which hormonal method was used. Lina Morch, a research epidemiologist
at the University of Copenhagen, who led the study, says the team found “a
roughly 20 percent increased risk [of breast cancer] among women who currently
use some type of hormonal contraceptive.” The longer the women used hormonal
methods, the higher their risk.

While many doctors and users have assumed a lower dose of
hormones meant a lower risk of cancer, the truth is that the same elevated risk
is present in either dose. In an editorial commentary accompanying the new
study, David J. Hunter, a professor of epidemiology and medicine at the
University of Oxford, explains the new study did not find any modern
contraceptives were risk-free. “There was a hope that the contemporary
preparations would be associated with lower risk,” he said in an interview.
“This is the first study with substantial data to show that’s not the case.”

For now, we’re hopeful that new contraceptive methods (ones
that don’t elevate this risk at all) will surface. Until then, a conversation
with your doctor about the best options for you is a great place to start.


By | 2017-12-07T20:43:32+00:00 December 7th, 2017|Categories: Plastic Surgery|0 Comments

Leave A Comment